Table 3.
Treatments | Strength of Ventralization | |||||
No. | Wild | V1 | V2 | V3 | V4 | |
(%) | (%) | (%) | (%) | (%) | ||
Uninjected | 40 | 100 | 0 | 0 | 0 | 0 |
bmp2b mRNA (50 pg) | 62 | 0 | 0 | 6 | 18 | 76 |
bmp2b mRNA (50 pg) glce-A MO (8 ng) glce-B MO (8 ng) |
60 | 15 | 15 | 31 | 25 | 16 |
bmp4 mRNA (100 pg) | 60 | 0 | 0 | 0 | 15 | 85 |
bmp4 mRNA (100 pg) glce-A MO (8 ng) glce-B MO (8 ng) |
60 | 21 | 18 | 23 | 23 | 15 |